Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications

Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network.

Frontiers in oncology·2026

Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network.

Frontiers in oncology·2026

First-in-human study of a thorium-227-labeled mesothelin-targeting antibody-chelator conjugate (MSLN-TTC), in patients with malignant mesothelioma and other solid tumors.

ESMO open·2025

Overview on novel strategies and current guidelines for hematopoietic stem cell mobilisation and collection.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2023

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study.

Frontiers in pharmacology·2023

[Cultured platelets].

Bulletin de l'Academie nationale de medecine·2020

Autoimmune and inflammatory diseases associated with T-cell clonal expansion.

Haematologica·2026

Macrophage-specific LAMTOR2 deletion disrupts systemic iron homeostasis in mice.

Haematologica·2026

Dual inhibition of JAK and MEK suppresses T-cell acute lymphoblastic leukemia induced by mutant IL7R and RASGRP1 overexpression.

Haematologica·2026

Validation of the International Working Group 2023 response criteria for higher risk myelodysplastic syndromes/neoplasms using the International Consortium for Myelodysplastic Syndromes VALIDATE database and a randomized phase III trial.

Haematologica·2026

Preserving anthracycline-containing treatment in older patients with classical Hodgkin lymphoma: a role for liposomal doxorubicin. Comment on: "Age, anthracycline and mortality in 28,000 classic Hodgkin lymphoma patients: cohort study of a complete population".

Haematologica·2026

Mesenchymal stem cells in ribosomal insufficiency lead to aberrant osteoblastic differentiation and altered hematopoiesis.

Haematologica·2026

Cytomegalovirus Infections Following Pediatric Hematopoietic Stem Cell Transplantation: An 18-Year Single-Center Experience.

Transplant infectious disease : an official journal of the Transplantation Society·2026

Complete radiological and biochemical remission at 26 months in a young adult with primary mediastinal yolk sac tumor: a case report and literature review on multimodal management.

Journal of medical case reports·2026

Making space for cures: Conditioning for autologous hematopoietic stem cell gene therapies.

Seminars in hematology·2026

Charge Comparison of Standalone Middle Meningeal Artery Embolization to Non-surgical Medical Management for Chronic Subdural Hematoma - A Propensity Score Matched Analysis.

World neurosurgery·2026

Real-World Outcomes of PRESERFLO MicroShunt Implantations With and Without Adjunctive Healaflow® Application in Glaucoma Patients: A Single-Center Experience.

Klinische Monatsblatter fur Augenheilkunde·2026

Generation of a human induced pluripotent stem cell line (ZZUNEUi040-A) from a male patient with hypertrophic cardiomyopathy carrying a heterozygous TPM1 (c.644C > T) mutation.

Stem cell research·2026

Related Experiment Videos

Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications

Related Concept Videos

Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network.

Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network.

First-in-human study of a thorium-227-labeled mesothelin-targeting antibody-chelator conjugate (MSLN-TTC), in patients with malignant mesothelioma and other solid tumors.

Overview on novel strategies and current guidelines for hematopoietic stem cell mobilisation and collection.

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study.

[Cultured platelets].

Autoimmune and inflammatory diseases associated with T-cell clonal expansion.

Macrophage-specific LAMTOR2 deletion disrupts systemic iron homeostasis in mice.

Dual inhibition of JAK and MEK suppresses T-cell acute lymphoblastic leukemia induced by mutant IL7R and RASGRP1 overexpression.

Validation of the International Working Group 2023 response criteria for higher risk myelodysplastic syndromes/neoplasms using the International Consortium for Myelodysplastic Syndromes VALIDATE database and a randomized phase III trial.

Preserving anthracycline-containing treatment in older patients with classical Hodgkin lymphoma: a role for liposomal doxorubicin. Comment on: "Age, anthracycline and mortality in 28,000 classic Hodgkin lymphoma patients: cohort study of a complete population".

Mesenchymal stem cells in ribosomal insufficiency lead to aberrant osteoblastic differentiation and altered hematopoiesis.

Cytomegalovirus Infections Following Pediatric Hematopoietic Stem Cell Transplantation: An 18-Year Single-Center Experience.

Complete radiological and biochemical remission at 26 months in a young adult with primary mediastinal yolk sac tumor: a case report and literature review on multimodal management.

Making space for cures: Conditioning for autologous hematopoietic stem cell gene therapies.

Charge Comparison of Standalone Middle Meningeal Artery Embolization to Non-surgical Medical Management for Chronic Subdural Hematoma - A Propensity Score Matched Analysis.

Real-World Outcomes of PRESERFLO MicroShunt Implantations With and Without Adjunctive Healaflow® Application in Glaucoma Patients: A Single-Center Experience.

Generation of a human induced pluripotent stem cell line (ZZUNEUi040-A) from a male patient with hypertrophic cardiomyopathy carrying a heterozygous TPM1 (c.644C > T) mutation.

Related Experiment Videos

Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications

Related Concept Videos

Related Articles